The Effect of Different Types of Progestin on Sleeping of Menopausal Women

NCT02086032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-05-31

No results posted yet for this study

Summary

Investigators have found that sleeping disorder is an important problem in menopausal women.

There have been papers reporting the effect of hormonal therapy on sleeping, but fews have reported the effect of different progestogens on sleeping quality. There is a need for more in-depth study and more conclusive evidence about the progestins which have the most beneficial effects on sleeping disorders in menopausal women.

This study is going to collect the data from newly identified menopausal patients who are eligible for continuous estrogen-progestogen therapy for their climacteric treatment. The affects of the therapy will be monitored for 3 months.

Conditions

  • Menopausal and Postmenopausal Disorders

Interventions

DRUG

1mg 17 beta-estradiol

Comparing sleeping quality between micronized progesterone and dydrogesterone users.

DRUG

Dydrogesterone

Comparing sleeping quality between micronised progesterone and dydrogesterone users.

DRUG

micronized progesterone

Comparing sleeping quality between micronised progesterone and dydrogesterone users

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Tawiwan Pantasri, MD · Faculty of Medicine, Chiang Mai University, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-06-30
Completion
2015-07-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02086032 on ClinicalTrials.gov